Addressing barriers to initiation of insulin in patients with type 2 diabetes

Mark Peyrot, Richard R. Rubin, Kamlesh Khunti

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Type 2 diabetes is progressive in nature and many people with the condition will inevitably require insulin therapy to attain and maintain adequate glycaemic control. In clinical practice, insulin initiation is delayed in many patients who would benefit from such treatment. Patients' and physicians' beliefs and perceptions regarding insulin therapy are known to create barriers contributing to the delay in its initiation. This article explores the nature of these barriers and offers suggestions and practical solutions for addressing and overcoming these hurdles so that insulin can be initiated confidently and appropriately in order to improve diabetes care.

    Original languageEnglish (US)
    Pages (from-to)S11-S18
    JournalPrimary care diabetes
    Volume4
    DOIs
    StatePublished - Apr 2010

    Keywords

    • Barrier resolution strategies
    • Insulin initiation
    • Patient barriers
    • Physician barriers

    ASJC Scopus subject areas

    • Internal Medicine
    • Endocrinology, Diabetes and Metabolism
    • Nutrition and Dietetics

    Fingerprint

    Dive into the research topics of 'Addressing barriers to initiation of insulin in patients with type 2 diabetes'. Together they form a unique fingerprint.

    Cite this